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ROBO1 is a receptor mediating Slit-induced repulsive action on axon guidance and differentially
expressed in human cancers. Although ROBO1 ectodomain has been detected, the cleavage site
had not been determined. In this study we identiﬁed the precise cleavage site of ROBO1. We also
report multi-step proteolysis of ROBO1 by metalloproteinases and c-secretase, producing two car-
boxy-terminal fragments, ROBO1-CTF1 at 129-kDa and ROBO1-CTF2 at 118-kDa. We have further
demonstrated nuclear accumulation of ROBO1, which is abolished by either a metalloproteinase
inhibitor TAPI-1 or a c-secretase inhibitor L-685,458. ROBO1 may function beyond the receptor
through stepwise cleavages and translocation to the nucleus.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
ROBO1, a member of immunoglobulin superfamily, plays an
important role in axon guidance in species from C. elegans to hu-
man [1–4]. Activation of ROBO1 receptor by SLIT2 ligand mediates
a repulsive response in pioneering axons and migratory neurons,
whereas Netrin – Deleted in Colorectal Carcinoma (DCC) signaling
has been implicated in attracting axons to the midline [5–7].
Involvement of Slit-Robo pathway in cancer development has been
also demonstrated [8–12]. Recombinant Slit2 protein inhibited
invasion of medulloblastoma cells in vitro [13], whereas over-
expression of SLIT2 in some cancer cell lines demonstrated induc-
tion of tumor angiogenesis by activating SLIT2-dependent ROBO1
signaling [14].
We previously showed an amino-terminal fragment of ROBO1
(ROBO1-NTF) at120-kDa protein were detectable in culture med-
ium of cancer cell lines and in sera from hepatocellular carcinoma
(HCC) patients, suggesting ROBO1 receptor might be subjected to
proteolytically cleaved in cancer cells [15]. Li and co-workers de-
tected the carboxy-terminal fragments of ROBO1 with a lower Mr
than a full-length ROBO1 with Mr of >200-kDa [16]. Although the
apparent shedding of ROBO1 was observed [15–17] and haschemical Societies. Published by E
Division, Research Center for
okyo, 4-6-1 Komaba, Meguro-
atani).potentially interesting biological implications, little is known of
the mechanism of the shedding and dynamics of carboxy-terminal
fragments of ROBO1 (ROBO1-CTF).
2. Materials and methods
2.1. Materials
Anti-ROBO1 monoclonal antibodies B5303A and A7241A were
generated by immunization of full-length ROBO1 or gp64-fused
ROBO1 fragments (22–113 a.a.), respectively (Supplementary
Fig. 1A). The epitope of B5303A was determined as 431–540 a.a.
by immunoblotting against a series of recombinant ROBO1 frag-
ments. ROBO1-CpAb, a polyclonal antibody to carboxy-terminal re-
gion of ROBO1, was generated by immunization of GST-fused
ROBO1 fragment (1455–1580 a.a.) as described before [18]. Details
of cell lines, antibodies, inhibitors and plasmids are provided in
Supplementary data.
2.2. Immunoblotting and immunocytochemistry
Immunoblot analyses were performed according to a previous
report [19]. Band intensity and relative molecular weight were
determined using LAS3000 ImageGauge software (Fuji-ﬁlm, Japan).
Immunocytochemistry was performed as described before [20].
ROBO1-CpAb (10 lg/ml) or anti-FLAG (1 lg/ml) antibody was used
as a primary antibody, and anti-mouse (10 lg/ml) or anti-rabbitlsevier B.V. All rights reserved.
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Fig. 1. Identiﬁcation of ROBO1 ectodomain by proteomic analysis. (A) SYPRO Ruby staining of immunoprecipitant with B5303A (upper). ROBO1 was detected at 120-kDa by
immunoblot analysis with A7241A (lower). Arrows indicate ROBO1 ectodomain. (B) ROBO1 peptide identiﬁed by LC–MS analysis and database searching. The amino acid
sequence of full-length ROBO1 is shown in single-letter code. The fragments covered by the LC–MS analysis are shown in gray. The most C-terminal peptide is underlined. (C)
MS/MS spectrum of the ROBO1 peptide from S828 to Q852. m/z, mass to charge ratio.
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ondary antibody. Propidium iodide (1 lg/ml) was used as a nuclear
indicator.
2.3. Amino acid sequence
Precleaned lysate was immunoprecipitated with anti-ROBO1
antibody (B5303)-bound magnetic beads for 16 h at 4 C, followed
by washing the beads. Immunoprecipitants were separated by
SDS–PAGE, and the bands were dissected. The amino acid sequence
of the peptide in-gel-digested by trypsin was identiﬁed by LC–MS/
MS analysis using LTQ orbitrap XL mass spectrometer (ThermoTable 1
The measured m/z values of b ions and y ions for the ROBO1 peptide from S828 to Q852.
b b++ Seq.
Measured Expected Measured Expected
88.0 44.5 S
217.1 109.0 E
314.1 157.6 P
442.2 221.6 Q
589.3 295.1 F
702.0 702.4 351.7 I
830.7 830.4 415.7 Q
943.4 943.5 472.3 L
1058.5 529.8 D
1129.6 565.3 A
1266.6 633.8 H
1323.6 662.3 G
1437.6 1437.7 719.5 719.3 N
1534.7 767.9 P
1633.8 817.4 817.4 V
1721.1 1720.8 860.8 860.9 S
1817.9 909.4 P
1946.9 974.0 973.9 E
2062.0 1031.5 D
2190.0 1095.5 Q
2289.1 1145.0 1145.0 V
2376.1 1188.8 1188.6 S
2489.2 1245.0 1245.1 L
2560.2 1280.5 1280.6 A
Q
b, singly charged b ion; b++, doubly charged b ion; Seq., amino acid sequence; y, singly
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Fig. 2. ROBO1 is proteolytically cleaved by metalloproteinases. (A) Immunoblotting of PL
MG-132. (B) Inhibition of ROBO1-cleavage by metalloproteinase inhibitors. PLC/PRF/5 cel
and either GM6001 or TAPI-1. ROBO1 was detected by immunoblot analysis with ROBOFisher Scientiﬁc, Waltham, MA). Details of the analysis are pro-
vided in Supplementary data.
3. Results and discussion
Although we previously detected ROBO1-NTF in the culture
supernatant of liver cancer cells and sera from HCC patients, the
cleavage site of ROBO1 had not been determined [15]. In this study
we examined the precise cleavage site of ROBO1 using a proteomic
approach. We collected ROBO1 ectodomain by immunoprecipita-
tion (Fig. 1A), and performed LC–MS/MS analysis of a gel slice at
120-kDa protein (Fig. 1B). Tandem MS analysis identiﬁed ay y++
Measured Expected Measured Expected
2619.3 1310.1
2490.2 1244.9 1245.6
2393.2 1197.1
2265.1 1133.1
2118.1 1059.5 1059.5
2005.0 1002.9 1003.0
1876.9 938.6 939.0
1763.8 882.2 882.4
1648.8 824.4 824.9
1577.8 789.4
1440.7 720.9
1383.2 1383.7 692.3
1269.6 1269.6 635.3
1172.7 1172.6 586.8
1073.4 1073.5 537.3
986.1 986.5 493.7
888.8 889.4 444.5 445.2
760.4 760.4 380.7
645.4 323.2
517.4 517.3 259.2
418.1 418.2 209.6
331.2 166.1
218.1 109.6
147.1 74.0
charged y ion; y++, doubly charged y ion.
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2912 M. Seki et al. / FEBS Letters 584 (2010) 2909–2915peptide comprising residues 838–852, which was not a predicted
peptide product by trypsin-digestion, demonstrating the precise
cleavage site to shed ROBO1-NTF was between Glu852 and
Glu853, ten residues away from the plane of plasma membrane
(Fig. 1C and Table 1).
We thought ROBO1-CTF was retained in the vicinity of plasma
membrane or in cytoplasm and addressed the dynamics of
ROBO1-CTF with a newly generated ROBO1-CpAb, an antibody
against the carboxy-terminal region of ROBO1 (Supplementary
Fig. 1A). We detected bands at 120-kDa proteins, as well as
full-length ROBO1 at 250-kDa protein in PLC/PRF/5 cells (Supple-
mentary Fig. 1B). The fragments at 120-kDa proteins were accu-
mulated by exposure of cells with proteasome inhibitors MG-132
and MG-115 but not by calpain protease inhibitors Calpain inhibi-
tor I and Calpain inhibitor II, suggesting the fragments might be
rapidly degraded via the ubiquitin-proteasome pathway under a
physiological condition (Supplementary Fig. 1C). We conﬁrmed
that 120-kDa proteins, candidates of a carboxy-terminal frag-CTF1
CTF2
120
100
α-tubulin
L-
68
5,
45
8
D
M
SO
PLC/
(ROBO
+ -
G
M
60
01
L-
68
5,
45
8
D
M
SO
D
M
SO
HEK-293, ROBO1-FL
(α-V5)
+ - - - MG-132
M r  
(kDa)
Ig Ig Ig Ig Ig FN
ROBO1-FL
ROBO1-ΔFNIII/ΔJM
M
G
-1
32
L-
68
5,
45
8
D
M
SO
FL ΔΔJM
M
G
-1
32
L-
68
5,
45
8
D
M
SO
D
M
SO
220
120
100
M r  
(kDa)
ROBO1-ΔFNIII
ROBO1-ΔJM
ralullecartxE
A
B
C
Fig. 3. Stepwise cleavage of ROBO1 by metalloproteinases and c-secretase. (A) Detecti
secretase inhibitor L-685,458. (B) Deletion constructs of V5-tagged ROBO1 proteins. FL, fu
deleted; DFnIII/DJM, both ﬁbronectin-type III domain- and juxta-membrane region-dele
anti-V5 antibody. PMA was added to cells at 24 h after transfection of the construct. MGment of ROBO1 (ROBO1-CTF), were derived from ROBO1 gene by
an RNA interference experiment (Supplementary Fig. 1D). While
immunoprecipitation of PLC/PRF/5 cells with ROBO1-CpAb fol-
lowed by immunoblotting with ROBO1-CpAb gave bands at 250
and 120-kDa proteins, only 250-kDa protein was detectable
by immunoprecipitants with ROBO1 ectodomain-recognizing anti-
body followed by immunoblotting with ROBO1-CpAb, supporting
the 120-kDa proteins were ROBO1-CTFs (Supplementary Fig. 1E).
Because the cleavage site was in the vicinity of plasma mem-
brane, we examined whether phorbol 12-myristate 13-acetate
(PMA) accelerated the cleavage or not. Exposure of the PMA-trea-
ted cells to MG-132 promoted the production of ROBO1-CTFs,
whereas the amount of full-length ROBO1 protein was decreased
by PMA-exposure (Fig. 2A). This result suggested that PMA-acti-
vated proteases such as metalloproteinases proteolytically cleaved
full-length ROBO1 and produced ROBO1-CTFs. Increased amount of
full-length ROBO1 and decreased amount of ROBO1-CTFs were ob-
served by exposure of PLC/PRF/5 cells to a broad-spectrum MMP120
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TAPI-1 (Fig. 2B), showing that metalloproteinases converted full-
length ROBO1 to ROBO1-CTFs.
We observed ROBO1-CTFs as two bands, ROBO1-CTF1 at 129-
kDa and ROBO1-CTF2 at 118-kDa by immunoblotting with a longerFig. 4. ROBO1 localizes in the nucleus. PLC/PRF/5 cells were exposed to GM6001 (D–F), L-
expressed ROBO1 was stained with ROBO1-CpAb (A, D, and G). COS-7 cells were transfect
length ROBO1 (ROBO1-FL-FLAG) (M–O). An anti-FLAG antibody was used for detecting ec
H, K, and N). Scale bars shown are 20 lm.migrating time in electrophoresis and enhanced chemilumines-
cence visualization (Fig. 3A). An accumulation of ROBO1-CTF1
was promoted by a c-secretase inhibitor L-685,458, whereas
ROBO1-CTF2 was at undetectable level (Fig. 3A, lane 2 of left and
right panels), suggesting that ROBO1-CTF1 was a substrate of685,458 (G–I) or DMSO (A–C), simultaneously with PMA and MG-132. Endogenously
ed with FLAG-tagged intracellular domain of ROBO1 (ROBO1-ICD-FLAG) (J–L) or full-
topically expressed ROBO1 (J and M). PI was used as an indicator of the nucleus (B, E,
2914 M. Seki et al. / FEBS Letters 584 (2010) 2909–2915c-secretase. We hypothesized that ROBO1 was subjected to
stepwise proteolysis, primarily by metalloproteinases and
subsequently by c-secretase. Metalloproteinases cleave juxta-
membrane region of transmembrane proteins [22]. We conﬁrmed
metalloproteinase-mediated production of ROBO1-CTF1 by using
a series of constructs of ROBO1 with in-frame deletion (Fig. 3B).
Both ROBO1-CTF1 and CTF2 were detectable in MG-132-treated
cells with juxta-membrane region-retained ROBO1 constructs,
full-length (FL) and a mutant deleted in the third ﬁbronectin-type
III domain (DFnIII) (Fig. 3C, lanes 3 and 9), whereas deletions of
both the third ﬁbronectin-type III domain and juxta-membrane re-
gion (DFnIII/DJM) resulted in decreasing signal intensity of the two
ROBO1-CTFs in MG-132-treated cells (Fig. 3C, lane 12). With expo-
sure of the cells to L-685,458, accumulation of ROBO1-CTF1 was
observed in FL- and DFnIII-transfected cells (Fig. 3C, lanes 2 and
8). We attempted to express a juxta-membrane-deleted mutant
of ROBO1 (DJM), but the expression of DJM in cell transfectants
was hardly detected. A Mr of endogenous ROBO1-CTF2, which
might be produced by c-secretase-mediated proteolysis, was cal-
culated as 119-kDa, far from the predicted molecular mass
(Fig. 3A). A c-secretase facilitates intramembrane endoproteolytic
cleavage [23]. ROBO1-CTF2 may be expected to possess intracellu-
lar domain with several amino acid residues in transmembrane re-
gion, giving the deduced molecular mass of 78 732–81 102. TheMr
of ectopically expressed intracellular domain of ROBO1 (ROBO1-
ICD) was also far apart from its deduced molecular mass (Supple-
mentary data). Previous reports also mentioned the discrepancy
between the predicted molecular mass of ROBO1 and the observed
Mr [17,24,25].
We observed nuclear localization of endogenous ROBO1 of PLC/
PRF/5, HepG2 and Huh7 cells (Supplementary Fig. 2). We nextROBO1
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-CTF2
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Fig. 5. Schematic representation of ROBO1 multi-step proteolysis and translocation
to the nucleus. First, ROBO1-NTF is shed by PMA-activated metalloproteinases into
the extracellular space. The shedding also produces ROBO1-CTF1. Metalloprotein-
ase inhibitors such as GM6001 and TAPI-1 block this proteolysis. ROBO1-CTF1, a
membrane-bound stub, is then cleaved by c-secretase to produce ROBO1-CTF2. This
secondary proteolysis can be inhibited by a c-secretase inhibitor L-685,458.
ROBO1-CTF2 is released from membrane and translocates to the nucleus.examined whether nuclear translocation could be abolished by
inhibition of metalloproteinases or c-secretase. Compared to con-
trol cells (Fig. 4A–C), the translocations were abolished by inhibi-
tors for metalloproteinases or c-secretase (Fig. 4D–I). The
localization of ROBO1 in MG-132-untreated cells was also ob-
served at plasma membrane (Supplementary Fig. 3). Biochemical
fractionation of MG-132-treated PLC/PRF/5 cells showed ROBO1-
CTF2 only in nucleus-fraction and ROBO1-CTF1 in both nucleus-
and membrane/cytosol-fraction (Supplementary Fig. 4). We also
performed subcellular localization analysis by transfection of
COS-7 cells with plasmid encoding FLAG-tagged intracellular do-
main of ROBO1 (ROBO1-ICD; 894–1615 a.a.). Ectopic ROBO1-ICD
was observed to be localized mainly in the nucleus (Fig. 4J–L),
whereas full-length ROBO1 was localized mainly at plasma mem-
brane (Fig. 4M–O).
ROBO1 is successively cleaved primarily by metalloproteinases
and subsequently by c-secretase: (i) two CTFs existed in MG-132-
treated liver cancer cells (Fig. 3A), suggesting ROBO1-cleavage is
composed of at least two-step processing, (ii) production of both
ROBO1-CTF1 and ROBO1-CTF2 was inhibited by either exposure
of cells to metalloproteinase inhibitors (Fig. 2B), showing metallo-
proteinase cleavage is essential for production of both ROBO1-CTF1
and ROBO1-CTF2, and (iii) inhibiting c-secretase activity increased
accumulation of ROBO1-CTF1 but not ROBO1-CTF2 (Fig. 3A and C),
demonstrating c-secretase cleaves ROBO1-CTF1 to produce
ROBO1-CTF2 (Fig. 5).
Successive cleavage by metalloproteinases and c-secretase,
called regulated intramembrane proteolysis (RIP), has been also
reported in several transmembrane proteins [26–29]. Carboxy-
terminal fragments of these proteins are released from membrane
through multi-step proteolysis. The fragments then migrate to the
nucleus and activate transcription of target genes [30]. Nuclear
translocation mediated by metalloproteinase/c-secretase-cleavage
supports ROBO1 is a new member of RIP-processed protein fam-
ily. We found three deduced nuclear localization sequences (NLSs)
at 884–889, 1253–1259 and 1424–1430 a.a., however could not
abolish nuclear translocation of NLS-deleted ROBO1 mutant (data
not shown). It has been reported that ROBO1 interacts with mol-
ecules, which plays a role in signal transduction. Nuclear translo-
cation of ROBO1 may be controlled by interactive molecules.
Whether cleavages of ROBO1 by metalloproteinases/c-secretase
are dependent on a SLIT2 ligand or not should also be further
examined.
In summary, we show evidence for multi-step proteolysis of
ROBO1 and translocation to the nucleus of cancer cells. These re-
sults provide a more complete picture of the post-translational
processing of ROBO1 in cancer cells, and permit us to speculate
that ROBO1 may function beyond the receptor as a signaling mol-
ecule through stepwise cleavages and translocation to the nucleus.Acknowledgements
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